Letters
The “Saatchi bill”
“Saatchi bill”: legal hurdles and clinical irrelevance
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3146 (Published 14 May 2014) Cite this as: BMJ 2014;348:g3146
- Santhanam Sundar, consultant oncologist1
- 1Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK
- sundar{at}oncology.org
The “Saatchi law” was drafted with the noblest of intentions but it faces serious hurdles in achieving the aim of promoting innovative treatments.1
Firstly, the bill needs to be reconciled with various mandatory EU directives on medicinal products.2 As the Medicines and Healthcare Products Regulatory Agency states, the EU “Directive 2001/83/EC relating to medicinal products …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.